Norditropin (Novo Nordisk)
(https://norditropin.com) 📸 Data Snapshot: May 30, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
The primary authority gap is technical; the schema_json is null across all pages, indicating a lack of structured data to define the organization or product for search engines. While experts are not named individually (common in pharma to avoid off-label liability), the brand’s authority is tied to NovoCare and Novo Nordisk. There are no Person schema or sameAs links for medical directors, which is a missed opportunity for establishing individual professional authority.
The disconnect is minimal because performance claims are legally constrained and must be cited. The claim of being the #1 prescribed therapy is anchored to a specific February 2026 date and source (Komodo Sentinel), preventing it from being a vague marketing assertion. The ease of use claim is not a subjective marketing boast but is tied to a specific study metric (6.7/7 rating).
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /support-savings/financial-assistance.html | 0 | 0 |
| /about.html | 0 | 0 |
| /taking.html | 0 | 0 |
This page presents a snapshot of public data from Norditropin (Novo Nordisk), captured on May 30, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Norditropin (Novo Nordisk): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://norditropin.com to view the most current version of its content and see directly what this company is about and what it offers.